Home > ASQ Washington, DC &... > Events > Attend an Event > Performance Excellence... Printable Version Tell a friend
Performance Excellence Special Interest Group Meeting
WMATA (Metro Headquarters)
600 5th St. NW
Washington D.C. 20001
Apr 11 6:00 pm - 8:00 pm (GMT -5:00) EST
Performance Excellence Special Interest Group
Washington, D.C. and Maryland Metro – ASQ Section 509
"Leadership and Vision for
A High Performance Organization (HPO)"
Dr. Bernadette Dunham
(Director, U.S. Food and Drug Administration’s (FDA) Center for Veterinary Medicine.)
Thursday, April 11, 2013
Washington DC Metro Headquarters at Gallery Place
Program: A high performance organization (HPO) is one that is continually improving, learning, and working toward one’s mission by responding to input from inside and outside one’s organization. HPO success relies on balancing operations, staff, and culture.
- It is a long process, not a training event.
- It is a mind-set, not a set of steps.
- Upper management must champion the cause for the effort to continue.
- It must be sustained by all of us, holding each other accountable.
Learning Organizations, to quote Peter Senge, PhD, are where people continually expand their capacity to create the results they truly desire, where new and expansive patterns of thinking are nurtured, where collective aspiration is set free, and where people are continually learning to see the whole together.
This presentation will highlight the leadership style associated with the Center for Veterinary Medicine of US FDA, an example of an HPO. Readers/Participants are highly recommended to view Simon Sinek’s talk entitled “How great leaders inspire action” on TED talks. http://www.ted.com/talks/simon_sinek_how_great_leaders_inspire_action.html
Speaker Biography: Dr. Bernadette Dunham
Dr. Bernadette Dunham was appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) on January 7, 2008, by FDA Commissioner, Andrew C. von Eschenbach, MD. Prior to becoming CVM’s Director, Dr. Dunham had been CVM’s Deputy Director. Dr. Dunham also served as the Director of CVM’s Office of Minor Use and Minor Species (OMUMS) from August 2006 to January 2008. She came to CVM in December 2002 as the Deputy Director of CVM’s Office of New Animal Drug Evaluation (ONADE). Dr. Dunham is also an Adjunct Professor in the Department of Biomedical Sciences and Pathobiology at the Virginia‐Maryland Regional College of Veterinary Medicine, a position she has held since 1996. She lectures on a variety of topics from emerging issues and opportunities in veterinary medicine to the role of consensus building in policy development.
Prior to joining FDA, Dr. Dunham was Acting Director for the American Veterinary Medical Association’s (AVMA) Governmental Relations Division in Washington, DC. In that position, she participated in the formation and execution of AVMA policies, objectives and programs, with emphasis on Federal legislation and regulatory issues. Dr. Dunham’s work also involved identifying Congressional and regulatory issues that might impact the veterinary medical profession, as well as developing strategies for response to these issues. Dr. Dunham was with the AVMA from 1995 to 2002, first as an Assistant Director and later as the Acting Director of the Governmental Relations Division. From 1989 to 1995, Dr. Dunham was the Director of Laboratory Animal Medicine and Adjunct Professor of Pharmacology at the State University of New York Health Science Center in Syracuse, NY, with her research focused on the molecular regulation of cardiac gap junction proteins. She participated in a post‐doctoral residency program in the Department of Pathology at the New York State College of Veterinary Medicine, Cornell University, Ithaca, NY, from 1987 to 1988. Dr. Dunham was a Research Assistant Professor at Boston University from 1984 to 1987. Prior to returning to academia to pursue her PhD, Dr. Dunham was in private practice in Ontario, Canada from 1975 to 1979. Dr. Dunham received the degree of Doctor of Veterinary Medicine in 1975 from the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and her PhD in cardiovascular physiology from Boston University in Boston, MA.
Dr. Dunham is a member of AVMA, the American Academy of Veterinary Pharmacology and Therapeutics, and the American Society for Laboratory Animal Practitioners. She has served on peer review panels for the National Academies of Science, the American Heart Association ‐ New York State Affiliate, United States Department of Agriculture‐Cooperative State Research, Education and Extension Service, Competitive Programs, and the National Institutes of Health. Dr. Dunham also served as the Chairperson for the 18th Session of the Codex Alimentarius Committee on Residues of Veterinary Drugs in Foods.
Escort & Networking: 6:00 p.m.
Meeting Kick-off: 6:30 p.m.
Adjourn: 8:00 p.m.
Registration: The event is free of charge. Participants are invited to pre-register at the ASQ Section 509 website: Performance Excellence SIG Meeting - April 2013 and attend the networking portion of the meeting, which includes free pizza and soft drinks.